๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia

โœ Scribed by Stirewalt, D. L.

Book ID
111655863
Publisher
American Society of Hematology
Year
2001
Tongue
English
Weight
506 KB
Volume
97
Category
Article
ISSN
0006-4971

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

RAS, FLT3, and TP53 mutations in therapy
RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7
โœ Lucy E. Side; Nicole P. Curtiss; Kathryn Teel; Christian Kratz; Pauline W. Wang; ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB

## Abstract Oncogenic mutations in the __KRAS2__, __NRAS__, or __FLT3__ gene are detected in more than 50% of patients with de novo acute myeloid leukemia (AML). __RAS__ mutations are also prevalent in de novo myelodysplastic syndrome (MDS), especially chronic myelomonocytic leukemia and juvenile m

P077 NPM1 and FLT3 mutations in acute my
P077 NPM1 and FLT3 mutations in acute myeloid leukemia
โœ S. Nahajevszky; A. Tordai; A. Szilvasi; N. Meggyesi; E. Adam; A. Kozma; S. Lueff ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 58 KB

Recognition of specific skin manifestations of acute myelogenous leukemia is important because they have prognostic value and always indicates poor prognosis. P074 Jumping translocation of 1q in a case of childhood acute lymphoblastic leukemia, type L3 with t(8;14